menu search

novartis completes sandoz spinoff

novartis has completed the planned spin-off of its generics and biosimilars business Sandoz , the Swiss...

October 4, 2023, 1:20 am

novartis (nvs) announces positive data on kidney disease drug

novartis' (NVS) phase III study on pipeline candidate iptacopan in patients with IgAN shows superiority...

October 3, 2023, 1:32 pm

novartis positioning is now best-suited for long-term gains and returns after spin-off, says ceo

novartis CEO Vas Narasimhan joins 'Squawk on the Street' to discuss the company's new spin-off Sandoz, ...

October 3, 2023, 12:08 pm

novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off

Vas Narasimhan, CEO at novartis, discusses the company's 100% spin off of Sandoz, its generic and biosi...

October 3, 2023, 11:26 am

Here's why novartis (nvs) is a strong value stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre...

October 3, 2023, 11:17 am

Drugmakers sign on to negotiate medicare prices under protest

All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, includin...

October 2, 2023, 1:02 pm

novartis' (nvs) sandoz gets ec nod for tysabri's biosimilar

novartis' (NVS) Sandoz broadens its biosimilar portfolio with Tyruko's approval, a biosimilar of the mu...

September 26, 2023, 1:31 pm

novartis: buy this dividend aristocrat for consistent income

novartis' core EPS payout ratio is poised to come in at around 51% in 2023. The Swiss drugmaker grew at...

September 26, 2023, 7:17 am

novartis (nvs) lutathera meets primary goal in phase iii study

novartis' (NVS) radioligand therapy Lutathera reports statistically significant and clinically meaningf...

September 25, 2023, 1:32 pm

Morgan stanley sees biopharma sector as a 'safe haven'

Morgan Stanley (NYSE:MS) expects the EU biopharma sector to offer a safe haven from weakening growth/higher real yields. “Whilst we continue to favo...

September 25, 2023, 10:01 am

novartis confirms sandoz spin-off for october 4, 2023

novartis on Monday confirmed its plans for a 100% spin-off of the Sandoz business on Oct. 4 after share...

September 25, 2023, 1:22 am

Beigene regains rights for cancer drug after novartis deal termination

BeiGene said on Tuesday it would regain rights to develop and manufacture its cancer drug after a deal termination with ...

September 19, 2023, 6:14 am

novartis' (nvs) shareholders approve sandoz separation

novartis' (NVS) shareholders vote in favor of the 100% spin-off of Sandoz into a new publicly traded st...

September 18, 2023, 1:33 pm

novartis shareholders vote in favour of sandoz spin-off

novartis shareholders on Friday voted in favour of spinning off the Swiss company's generic-drugs busin...

September 15, 2023, 5:34 am

novartis' (nvs) sandoz gets rights for stelara biosimilar

novartis (NVS) announces an agreement with Samsung Bioepis for exclusive rights to commercialize the bi...

September 12, 2023, 1:35 pm

Nvs vs. lly: which stock is the better value option?

Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with novartis (NVS) and El...

September 12, 2023, 12:50 pm

Uk's syncona writes off 54.5 mln stg after novartis ends gyroscope's therapy

British healthcare investment firm Syncona said on Monday novartis has stopped the development of exper...

September 11, 2023, 2:44 am

Roche open to big acquisitions 'if it makes scientific and financial sense' - ceo tells newspaper

Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $2...

September 9, 2023, 3:50 pm

Here's why novartis (nvs) is a strong value stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

September 6, 2023, 11:18 am

novartis names new board member after international boss steps down

novartis has appointed AbbVie executive Patrick Horber to its executive committee, the Swiss pharmaceut...

September 6, 2023, 1:40 am


Search within

Pages Search Results: